Kenaject-40 Interactions
There are 589 drugs known to interact with Kenaject-40 (triamcinolone), along with 23 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 101 are major, 455 are moderate, and 33 are minor.
- View all 589 medications that may interact with Kenaject-40
- View Kenaject-40 alcohol/food interactions (2)
- View Kenaject-40 disease interactions (23)
Most frequently checked interactions
View interaction reports for Kenaject-40 (triamcinolone) and the medicines listed below.
- acetaminophen
- acetaminophen / hydrocodone
- allopurinol
- Arimidex (anastrozole)
- atorvastatin
- azithromycin
- benzonatate
- calcium / vitamin d
- cephalexin
- docusate
- famotidine
- gabapentin
- ibuprofen
- lamotrigine
- levothyroxine
- lorazepam
- melatonin
- montelukast
- Mucinex (guaifenesin)
- nitrofurantoin
- omeprazole
- prednisone
- selenium
- tamsulosin
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- vitamin e
- Voltaren Arthritis Pain Gel (diclofenac topical)
- zolpidem
Kenaject-40 alcohol/food interactions
There are 2 alcohol/food interactions with Kenaject-40 (triamcinolone).
Kenaject-40 disease interactions
There are 23 disease interactions with Kenaject-40 (triamcinolone) which include:
- infections
- prematurity
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
More about Kenaject-40 (triamcinolone)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.